Mesotherapy in the Treatment of Chronic Migraine
- Conditions
- Chronic Migraine, Headache
- Interventions
- Drug: Lidocain
- Registration Number
- NCT06118190
- Brief Summary
Mesotherapy is a type of injection frequently used in clinics. It is a treatment procedure that involves the injection of some drugs under the skin or into the skin. Mesotherapy is used in musculoskeletal system diseases, but it is reported that the effects of its use in migraine are uncertain.
- Detailed Description
Migraine is one of the types of headaches. For the diagnosis of chronic migraine, the headache must last more than 15 days. Nerve blocks, oral medication and neuromodulation are recommended for migraine treatment.Mesotherapy is a type of injection frequently used in clinics. It is a treatment procedure that involves the injection of some drugs under the skin or into the skin. Mesotherapy is used in musculoskeletal system diseases, but it is reported that the effects of its use in migraine are uncertain. This study was planned to show the effectiveness of mesotherapy in patients with migraine.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 27
- Clinical diagnosis of chronic migraine disease
- Infection disease
- Thyroid disease
- Anemia disease
- Systemic disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description mesotherapy Lidocain All participants who received mesotherapy were monitored regularly for the following three months to assess their prognosis and ensure patient adherence to treatment.
- Primary Outcome Measures
Name Time Method Visual Analog Scale (VAS) 12 th week VAS rates pain on a scale of zero to 10. It is explained to the participant that 10 points means unbearable pain, zero points means no pain, and the patient is asked to rate his pain between zero and ten. Higher scores indicate increased pain severity
The frequency of painful days per month 12th week The participant is asked how many days she/he feels pain in a month.Higher numbers indicate increased frequency of painful days
- Secondary Outcome Measures
Name Time Method Duration of attack per month 12th week The participant is questioned about how long each attack lasts within a month. Increased periods indicate prolonged symptom duration.
the number of analgesic per month 12th week The participant is asked how many times he/she uses analgesic medication in a month. Higher numbers indicate an increased need for medical treatment
Trial Locations
- Locations (1)
Kanni Sultan Suleyman Research and Training Hospital
🇹🇷Istanbul, Kucukcekmece, Turkey